http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015284430-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19bcbe24119dc0c46be035b333e5dc1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cfe5052053f7e7c6a96cdce8e9f72db |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fe3fa7b02ce85bf9b17b2ecbb57c9e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2183de47c5dc0dba300f1435e9035bc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e66caebc874f067d4979300e938093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eac1845746e554c752e79f68209b70e |
| publicationDate | 2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2015284430-A1 |
| titleOfInvention | Application of sp peptide or derivative thereof in preparing medicines for preventing or treating asthma |
| abstract | The present invention provides an application of an SP peptide or a derivative thereof in preparing medicines for preventing or treating asthma. The peptide or the derivative thereof is the SP peptide shown in Formula I or a pharmaceutically acceptable salt or ester thereof. The present invention also provides a method for treating asthma, the method comprises: administering to a patient with medicine containing the peptide or the derivative thereof with an effective therapeutic dosage. It proves through researches of the present invention that, the peptide or the derivative thereof can effectively alleviate pathological symptoms of asthma, especially pathological symptoms of allergic asthma. In the formula (I), Xaa1 is deletion, Ala, Gly, Val, Leu or Ile; Xaa2 is Thr or Ser; Xaa3 is Tyr, Phe or Trp; and Xaa4 is deletion, Ala, Gly, Val, Leu, Ile or Pro. n Xaa1-Gln-Xaa2-Xaa3-Thr-Ser-Gly-Xaa4 (Formula I) |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112824428-A |
| priorityDate | 2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.